Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,540 | -56,974 | -25,011 | -100,697 | -72,367 |
| Depreciation Amortization | -5,666 | -3,990 | -1,966 | -5,137 | -3,277 |
| Other Working Capital | -2,412 | -4,801 | -8,167 | 4,898 | 2,914 |
| Other Operating Activity | 15,010 | 9,954 | 4,958 | 15,248 | 11,312 |
| Operating Cash Flow | $-84,608 | $-55,811 | $-30,186 | $-85,688 | $-61,418 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,549 | -43,037 | -61,650 | -42,554 | -63,574 |
| PPE Investments | -969 | -551 | -218 | -849 | -792 |
| Investing Cash Flow | $-20,518 | $-43,588 | $-61,868 | $-43,403 | $-64,366 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 126,140 | 126,014 | 125,198 | 85,885 | 85,431 |
| Other Financing Activity | -168 | -168 | -168 | -227 | -226 |
| Financing Cash Flow | $125,972 | $125,846 | $125,030 | $85,658 | $85,205 |
| Beginning Cash Position | 23,875 | 23,875 | 23,875 | 67,308 | 67,308 |
| End Cash Position | 44,721 | 50,322 | 56,851 | 23,875 | 26,729 |
| Net Cash Flow | $20,846 | $26,447 | $32,976 | $-43,433 | $-40,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -84,608 | -55,811 | -30,186 | -85,688 | -61,418 |
| Capital Expenditure | -969 | -551 | -218 | -849 | -792 |
| Free Cash Flow | -85,577 | -56,362 | -30,404 | -86,537 | -62,210 |